Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USPTO

USPTO

posted on Nov 19, 2007 07:47AM

The stay does not preclude the possibility of an announcement from the USPTO, on the reexamination, during the 30 day period.

 

 

 Be well

Share
New Message
Please login to post a reply